Treatment of Urinary Tract Infections (UTIs)
For uncomplicated cystitis, nitrofurantoin 100 mg twice daily for 5 days is the recommended first-line treatment due to its high efficacy and low resistance rates. 1, 2
First-Line Treatment Options for Uncomplicated UTIs
Uncomplicated Cystitis in Adults
- Nitrofurantoin: 100 mg twice daily for 5 days 1, 2
- Fosfomycin trometamol: 3 g single dose 2
- Pivmecillinam: 400 mg three times daily for 3-5 days 2
- Trimethoprim-sulfamethoxazole (TMP-SMX): 160/800 mg twice daily for 3 days (only if local resistance rates <20%) 1, 2, 3
Duration of Treatment for Uncomplicated Cystitis
| Antimicrobial | Duration |
|---|---|
| Nitrofurantoin | 5 days |
| Fosfomycin | Single dose |
| TMP-SMX | 3 days |
| Pivmecillinam | 3 days |
| Fluoroquinolones | 3 days (not recommended as first-line due to collateral damage) |
Treatment for Complicated UTIs
Pyelonephritis
Oral therapy (for mild to moderate cases):
Initial IV therapy (for severe cases, followed by oral therapy):
Catheter-Associated UTI
- Remove or change catheter if possible
- Treatment duration based on severity and response to therapy
- Consider local resistance patterns when selecting antimicrobials
Special Populations
Pregnant Women
- Avoid TMP-SMX in first and third trimesters 2
- Fosfomycin is a recommended option 2
- Screen all pregnant women for asymptomatic bacteriuria in first trimester 2
Men with UTI
- Longer treatment duration (7 days) recommended 2
- Consider evaluation for underlying structural abnormalities
Recurrent UTIs
- Non-antimicrobial interventions should be tried first:
- Increased fluid intake
- Proper hygiene practices
- Urinating before and after sexual activity
- If non-antimicrobial interventions fail, consider prophylaxis:
- Methenamine hippurate: 1 gram twice daily
- Low-dose post-coital antibiotic (single dose within 2 hours of intercourse)
- Low-dose daily antibiotic for 6-12 months 2
Important Considerations
Antimicrobial Resistance
- Obtain urine culture before starting antibiotics for complicated UTIs, suspected pyelonephritis, persistent/recurrent symptoms, or in pregnant women 2
- Avoid fluoroquinolones as first-line therapy due to increasing resistance and adverse effects 2
- Check local resistance patterns before prescribing TMP-SMX (should only be used if local resistance <20%) 2, 4
Common Pitfalls to Avoid
- Treating asymptomatic bacteriuria unnecessarily (except in pregnant women) 2
- Using broad-spectrum antibiotics for uncomplicated UTIs
- Prolonged treatment courses that increase risk of resistance without improving outcomes
- Failure to adjust therapy based on culture results in complicated cases
- Using agents with antipseudomonal activity in patients without risk factors for nosocomial pathogens 1
Algorithm for UTI Treatment Decision-Making
Assess severity and complication factors:
- Uncomplicated: healthy non-pregnant women with normal urinary tract
- Complicated: men, pregnant women, abnormal urinary tract, immunocompromised, healthcare-associated
For uncomplicated cystitis:
- Start with nitrofurantoin, fosfomycin, or pivmecillinam
- Use TMP-SMX only if local resistance <20%
For pyelonephritis:
- Mild-moderate: oral β-lactams or fluoroquinolones
- Severe: initial IV therapy with ceftriaxone, then step down to oral therapy
For complicated UTIs:
- Obtain cultures before starting antibiotics
- Consider broader coverage based on risk factors
- Adjust therapy based on culture results
By following these evidence-based recommendations, clinicians can effectively treat UTIs while minimizing antimicrobial resistance and optimizing patient outcomes.